Effect of crystalloid and colloid solutions on blood rheology in sepsis

Shock

Volumn 8, Issue 2, 1997, Pages 104-107

  Castro, Victor J ^a   Astiz, Mark E ^a   Rackow, Eric C ^a  

^a ST VINCENT S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINOID; HETASTARCH;

AGED; ARTICLE; BLOOD; BLOOD VISCOSITY; COLLOID; DRUG EFFECT; HUMAN; MIDDLE AGED; SEPSIS; SOLUTION AND SOLUBILITY;

AGED; ALBUMINS; BLOOD VISCOSITY; COLLOIDS; HETASTARCH; HUMANS; MIDDLE AGED; SEPSIS; SOLUTIONS;

EID: 0031205616     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199708000-00007     Document Type: Article

References (26)

1. Townsend M, Hampton W, Haybron D, Schirmer W, Fry D: Effective organ blood flow and bioenergy states in murine peritonitis. Surgery 100:205-212, 1986.
2. Lang C, Bagby G, Ferguson G, Spitzer J: Cardiac output and redistribution of organ blood flow in hyper-metabolic sepsis. Am J Physiol 1246:R331-R337,1984.
3. Astiz M, DeGent G, Lin R, Rackow E: Microvascular function and rheologic changes in hyperdynamic sepsis. Crit Care Med: 23:265-271, 1995.
4. Tighe D, Moss R, Haywood G: Dopexamine hydrochloride maintains portal blood and attenuates hepatic ultrastructural changes in a porcine peritonitis model of multiple system organ failure. Circ Shock 39:199-206, 1993.
5. Lam C, Tyml K, Martin C, Sibbald W: Microvascular perfusion is impaired in a rat model of normotensive sepsis. J. Clin. Invest 94:2077-2083,1994.
6. Yodice P, Astiz M, Kurian B, Lin R, Rackow E: Neutrophil rheologic changes in septic shock. Am J Repir Crit Care Med 155:38-42, 1997.
7. Hurd T, Dasmahaptura B, Rush B, Machiedo G: Red cell deformability in human and experimental sepsis. Arch Surg 123:217-220, 1988.
8. Scholz P, Karris J, Gump F, Kinney J, Chien S: Correlation of blood rheology with vascular resistance in critically ill patients. J Appl Physiol 49:1008-1011, 1975.
9. Astiz M, Galera-Santiago A, Rackow E: Intravascular volume and fluid therapy for severe sepsis. New Horizons 1:127-136,1993.
10. Ehrly A, Landgraf H: Influence of intravenous infusions of hydroxyethyl starch (MES) (MW 40,000 and 450,000) on the blood How properties of healthy volunteers. Angiology 36:41-44, 1985.
11. Corry W, Jackson L, Seaman G: Action of hydroxyethyl starch on the flow properties of human erythrocyte suspensions. Biorheology 20:705-717, 1983.
12. ACCP/SCCM Consensus conference: Definitions for sepsis and organ failure and guidelines for the use of vasoactive treatment in sepsis. Crit Care Med 20:864-874, 1992.
13. Reinhart W, Usami S, Schamalzer E, Lee M, Chein S: Evaluation of red . blood cell filterability test: Influences of pore size, hematocrit level and How rate. J Lab Clin Med 104:501-516, 1984.
14. International Committee for Standardization in Haematology. Guidelines for measurement of blood viscosity and erythocyte deformability. Clin. Hemorheol 6:439-453, 1986.
15. Todd J, Mollitt D: Sepsis-induced alterations in the erythrocyte membrane. Am Surgeon 60:954-957,1994.
16. Chein S, Usami S, Taylor H, Lindberg J, Grcgerson M: Effects of hematocrit and plasma proteins on human blood rheology at low shear rates. J. Appl Physiol. 21:81-87, 1976.
17. Ehrly A: The effect of plasma substitutes on erythrocyte aggregation and blood viscosity. Bibl Haemat 33;302-310, 1969.
18. Freyburger G, Dubruil M, Boisseau R, Janvier: Rbeological properties of commonly used plasma substitutes during preoperative normovolaemic acute haemodilution. British J Anaethesia 76:519-525, 1996.
19. Koyama T, Kikuchi Y: Reduced red cell filterability due to red cell plasma protein interactions. Biorheology 19:579-585, 1982.
20. Caines G, Goldstein J: NMR investigation of hydroxyethyl starch-induced aggregation of human erythrocytes. Magn Reson Med 5:67-72, 1987.
21. Chien S: Force balance at the surface of aggregating cells. Bibl Anat 11:303-309,1973.
22. Rackow E, Falk J, Fein A, Seigel J, Packman M, Haupt M, Kaufman B, Putnam D: Fluid resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solution in patients with hypovolemic and septic shock. Crit Care Med 11:839-850, 1983.
23. Langenfeld JE, Machiedo GW, Lyons M: Correlation between red blood cell deformability and changes in hemodynamic function. Surgery 116: 859-867, 1994.
24. Lipowsky H, Cram L, Justice W, Eppihimer M: Effect of erythrocyte deformability on in vivo red cell transit time and hematocrit and their correlation with in vitro filterability. Microvascular Res 46:43-64, 1993.
25. Collis R, Collins P, Gutteridge C, Kaul A, Newland A, Williams D, Webb A: The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation, an in vitro study. Intensive Care Med 20:37-41, 1994.
26. Boldt J, Muller M, Heesen M, Neumann K, Hempelmann G: Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 24:385-391, 1996.